NOCION THERAPEUTICS, INC.

Profile

Company Names

NOCION THERAPEUTICS, INC.

Addresses

15 MAIN STREET, NO. 247, WATERTOWN, MA 02472

100 BEAVER STREET, SUITE 308, WALTHAM, MA 02453

Phone Numbers

781-819-2877

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$76,112,511.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-12-15 
$22,999,999.00 
$22,999,999.00 
$0.00 
Equity 
3
2024-02-29 
$31,112,518.00 
$70,044,380.00 
$38,931,862.00 
Equity 
2
2021-08-18 
$6,999,997.00 
$16,999,993.00 
$9,999,996.00 
Equity 
1
2021-01-05 
$14,999,997.00 
$24,999,994.00 
$9,999,997.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JESSICA 
 
ALSTON 
DIRECTOR
NOCION THERAPEUTICS, INC.
RICHARD 
 
BATYCKY 
EXECUTIVE OFFICER, DIRECTOR
CIVITAS THERAPEUTICS, INC.   |  PULMATRIX, INC.   |  NOCION THERAPEUTICS, INC.
BRIDGET 
M. 
COLE 
EXECUTIVE OFFICER
NOCION THERAPEUTICS, INC.
PETER 
 
COUROSSI 
EXECUTIVE OFFICER
ACCELERON PHARMA INC   |  KALA PHARMACEUTICALS, INC.   |  TRACT THERAPEUTICS, INC.   |  NOCION THERAPEUTICS, INC.
FREDDIE 
 
DEAR 
DIRECTOR
NOCION THERAPEUTICS, INC.
JAMES 
 
ELLIS 
EXECUTIVE OFFICER
HUNTINGTON PARTNERS, LLLP   |  SADDLEWOOD ASSOCIATES, LLC   |  GORDON BIERSCH BREWING CO   |  SADDLEWOOD ASSOCIATES 2, LLC   |  NOCION THERAPEUTICS, INC.   |  LINWOOD COLLECTION LLC
MEREDITH 
 
FISHER 
DIRECTOR
OSCILLA POWER, INC.   |  PARTNERS INNOVATION FUND II, L.P.   |  MEDIAR THERAPEUTICS, INC.   |  ZIELBIO, INC.   |  ALBAMUNITY, INC.   |  NOCION THERAPEUTICS, INC.   |  CLARIS BIOTHERAPEUTICS, INC.   |  BRAVE BIO, INC.   |  FIRECYTE THERAPEUTICS, INC.   |  VIOLET THERAPEUTICS, INC.
MATTHEW 
 
FRANKEL 
EXECUTIVE OFFICER
CHEMOMAB THERAPEUTICS LTD.   |  NOCION THERAPEUTICS, INC.
JONATHAN 
 
GAREN 
EXECUTIVE OFFICER
NOCION THERAPEUTICS, INC.
JULIE 
 
GRANT 
DIRECTOR
REACTIVE BIOSCIENCES INC.   |  NOCION THERAPEUTICS, INC.   |  SOLSTICE ONCOLOGY, INC.
JULIE 
PAPANEK 
GRANT 
DIRECTOR
NOCION THERAPEUTICS, INC.
MICHAEL 
 
HIGGINS 
DIRECTOR
STAGE I DIAGNOSTICS, INC.   |  TGD ORLANDO, LLC   |  ARRIA NLG LTD   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  KINDEX PHARMACEUTICALS, INC.   |  GFM HOLDINGS, LLC   |  CAMP4 THERAPEUTICS CORP   |  GENOCEA BIOSCIENCES, INC.   |  NOCION THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.
ROSY 
 
HU 
DIRECTOR
APNIMED, INC.   |  NOCION THERAPEUTICS, INC.
MICHAEL 
 
LIPP 
EXECUTIVE OFFICER
NOCION THERAPEUTICS, INC.   |  DECOY THERAPEUTICS, INC.
VIJAY 
 
MURTHY 
DIRECTOR
METERA PHARMACEUTICALS INC.   |  TORPEDO DIAGNOSTICS, INC.   |  NOCION THERAPEUTICS, INC.
PINI 
 
ORBACH 
DIRECTOR
CENSA PHARMACEUTICALS INC.   |  AYALA PHARMACEUTICALS, INC.   |  NOCION THERAPEUTICS, INC.   |  AURON THERAPEUTICS, INC.   |  ENTACT BIO, INC.
CHRISTOPHER 
 
SILBER 
EXECUTIVE OFFICER
NOCION THERAPEUTICS, INC.
BERNARD 
 
SILVERMAN 
EXECUTIVE OFFICER
NOCION THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-12-15 
2024-03-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-29 
2022-08-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-18 
2021-08-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-18 
2021-01-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#